Our Approach To Cutaneous T-Cell Lymphoma in Adults

What Sets Us Apart

Cutaneous T-cell lymphoma is a form of cancer that develops when white blood cells grow and multiply uncontrollably in the skin. It is a chronic condition that requires ongoing care and monitoring. At NYU Langone’s Perlmutter Cancer Center, our oncologists, hematologists, and dermatologists work as a team to diagnose cutaneous T-cell lymphoma and provide treatments based on the latest scientific research. Integrative medicine specialists, psycho-oncologists, and social workers are also available to provide the support you need while managing this condition.


At NYU Langone’s Perlmutter Cancer Center, a National Cancer Institute-designated cancer center, we personalize the care of every patient.More About Perlmutter Cancer Center

CLINICAL TRIALS and Research Studies

Our teams of physicians and scientists work together across multiple disciplines to bring our patients the most innovative clinical trials.Find a Clinical Trial

Treatment at NYU Langone

Treatment for cutaneous T-cell lymphoma may include a combination of therapies, including medications applied directly to the skin, medications that affect the whole body (such as immunomodulators and chemotherapy), light therapy, radiation therapy, and stem cell transplantation.

More Resources